Gut bacteria transplant with diet and a diabetes drug for obesity and type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a combination of a fecal microbiota transplant (FMT), a calorie-restricted diet, and a type 2 diabetes medication (semaglutide) for people with obesity and recently diagnosed type 2 diabetes. The goal is to see if this approach can improve blood sugar control and weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your body mass index (BMI) is between 30 and 40.
- You were diagnosed with type 2 diabetes less than 1 year ago.
- You are a non-smoker or have quit smoking for more than 3 months.
- You do not have any serious liver or kidney problems.
- You have not taken certain medications (like antibiotics, acid reflux drugs, or probiotics) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device placed in the intestine to help control blood sugar and support weight loss in people with type 2 diabetes and obesity. It may offer a new option for managing both conditions together.
This trial tests whether transferring healthy stool bacteria from a lean donor can help improve blood sugar control in people with type 2 diabetes who still have high blood sugar 1-5 years after weight loss surgery.
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
This study tests whether a medication called semaglutide (which helps with weight loss) can change the bacteria in your gut, which might play a role in weight regulation. By participating, you may receive a treatment that could help you lose weight while researchers learn more about how it works.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help improve blood sugar and thyroid antibody levels in people with type 2 diabetes and Hashimoto's thyroiditis. If you qualify, you might get a chance to try this new approach.
This study tests whether transferring healthy stool bacteria into your gut (called fecal microbiota transplantation) can help improve blood sugar control and heart health in people with type 2 diabetes and heart disease. It is a small, early-stage study to see if the treatment is safe and well-tolerated.
Hear when a new Obesity Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.